Highlights: Incannex has engaged Fortrea as the contract research organisation (‘CRO’) to manage the IND opening Phase 2/3 clinical trial investigating.
Anorexia nervosa is a notoriously difficult illness to treat. It has the highest mortality rate of any psychiatric disorder, yet there is currently no FDA approved therapy for the condition.
The treatment combines Clearmind s MEAI, a novel proprietary psychedelic treatment for various addictions, and SciSparc s Palmitoylethanolamide , the active ingredient of its proprietary. | June 16, 2023